NCT04121494View on ClinicalTrials.gov

ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 22, 2019

Primary Completion Date

August 24, 2020

Study Completion Date

August 24, 2020

Conditions
Mycobacterium Tuberculosis, Protection AgainstTuberculosis
Interventions
BIOLOGICAL

ChadOx1 85A - aerosol

Aerosol administration through the Omron MicroAIR NE-U22 nebuliser

BIOLOGICAL

ChadOx1 85A - IM

Intramuscular administration

Trial Locations (1)

1011

Centre hospitalier universitaire vaudois, Lausanne

All Listed Sponsors
collaborator

University of Oxford

OTHER

lead

François Spertini

OTHER

NCT04121494 - ChAdOx1 85A Aerosol Versus Intramuscular Vaccination in Healthy Adults (TB039) | Biotech Hunter | Biotech Hunter